RxDoctor Payments Data

Brian Lieb, DO

Family Medicine · Carrolltown, PANPI 1871598268

Payments from drug & device makers

$1,946in general payments, 2019–2025

Across 112 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$252
  • AstraZeneca$247
  • Abbott$193
  • Novo Nordisk$187
  • Johnson & Johnson$182
  • Exact Sciences$177
  • plus $707 from 13 others

What the payments were for

  • Food & beverage$1,946100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,946 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$147,121
Medicare patients
210
Services billed
2,060

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban316$285,594
JardianceEmpagliflozin201$251,714
TrulicityDulaglutide103$131,616
FarxigaDapagliflozin Propanediol123$127,984
XareltoRivaroxaban97$115,810
OzempicSemaglutide78$113,179
JanuviaSitagliptin Phosphate64$91,027
TradjentaLinagliptin50$47,590
ProliaDenosumab19$32,314
InvokanaCanagliflozin28$25,180
Atorvastatin Calcium1,281$24,107
Breo ElliptaFluticasone/Vilanterol34$15,829
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$14,879
Lantus SolostarInsulin Glargine,hum.Rec.Anlog108$14,143
Fluticasone-SalmeterolFluticasone Propion/Salmeterol73$13,477

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$252$304,199262 claims
PfizerEliquis$137$285,594316 claims
Johnson & JohnsonXarelto, Invokana$182$140,990125 claims
Lilly USA, LLCTrulicity$29$131,616103 claims
AstraZenecaFarxiga$247$127,984123 claims
Novo NordiskOzempic$187$113,17978 claims
MerckJanuvia$107$91,02764 claims
GSKBreo Ellipta, Trelegy Ellipta$11$30,70858 claims
AbbVieSynthroid$17$2,96160 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Carrolltown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →